PLATELET FACTOR XIII IS AN ACTIVE ENZYME AFTER SOLUBILIZATION AND CROSSED IMMUNOELECTROPHORESISGOGSTAD GO; BROSSTAD F.1983; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1983; VOL. 29; NO 2; PP. 237-241; BIBL. 15 REF.Article

HALF-OF-THE SITES AND ALL-OF-THE SITES REACTIVITY IN HUMAN PLASMA BLOOD COAGULATION FACTOR XIIIAFOURE SEELIG G; FOLK JE.1980; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1980; VOL. 255; NO 20; PP. 9589-9593; BIBL. 17 REF.Article

SUBUNIT A OF FACTOR XIII REGULATES SUBUNIT B PLASMA CONCENTRATIONRODEGHIERO F; MORBIN M; BARBUI T et al.1981; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1981; VOL. 46; NO 3; PP. 621-622; BIBL. 15 REF.Article

NONCATALYTIC SUBUNITS OF HUMAN BLOOD PLASMA COAGULATION FACTOR XIII PREPARATION AND PARTIAL CHARACTERIZATION OF MODIFIED FORMSSEELIG GF; FOLK JE.1980; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1980; VOL. 255; NO 18; PP. 8881-8886; BIBL. 18 REF.Article

A TENTATIVE CLASSIFICATION OF FACTOR XIII DEFICIENCY IN TWO GROUPS.GIROLAMI A; BURUL A; FABRIS F et al.1977; ACTA HAEMATOL.; SUISSE; DA. 1977; VOL. 58; NO 5; PP. 318-320; BIBL. 5 REF.Article

GENETIC POLYMORPHISM OF THE B SUBUNIT OF HUMAN COAGULATION FACTOR XIIIBOARD PG.1980; AMER. J. HUM. GENET.; USA; DA. 1980; VOL. 32; NO 3; PP. 348-353; BIBL. 14 REF.Article

EEN ZELDZAME OORZAAK VAN EEN CONGENITALE BLOEDINGSNEIGING (FACTOR XIII DEFICIENTIE) = UNE CAUSE RARE DE TENDANCE CONGENITALE A L'HEMORRAGIE: DEFICIENCE EN FACTEUR XIIIVAN OOSTROM CG; VAN DE LOGT F.1980; T. KINDERGENEESKDE; NLD; DA. 1980; VOL. 48; NO 1; PP. 28-31; BIBL. 9 REF.Article

FACTOR XIIIKITCHENS CS; NEWCOMB TF.1979; MEDECINE; USA; DA. 1979; VOL. 58; NO 6; PP. 413-429; BIBL. 171 REF.Article

ON THE ACTIVATION OF BOVINE PLASMA FACTOR XIII. AMINO ACID SEQUENCE OF THE PEPTIDE RELEASED BY THROMBIN AND THE TERMINAL RESIDUES OF THE SUBUNIT POLYPEPTIDES.NAKAMURA S; IWANAGA S; SUZUKI T et al.1977; MEM. INST. PROTEIN RES., OSAKA UNIV.; JAP.; DA. 1977; VOL. 19; PP. 14Article

KONGENITALER FAKTOR XIII-MANGEL. PATHOPHYSIOLOGIE, SYMPTOMATOLOGIE UND THERAPIE MIT KASUISTISCHER NITTEILUNG EINES FALLES. = DEFICIT CONGENITAL EN FACTEUR XIII. PHYSIOPATHOLOGIE, SYMPTOMATOLOGIE ET TRAITEMENT A PROPOS D'UN CASNEIDHARDT B; MAEDER HU; FLUGEL H et al.1976; FORTSCHER. D. MED.; DTSCH.; DA. 1976; VOL. 94; NO 25; PP. 1319-1324; ABS. ANGL.; BIBL. 1 P.Article

SYSTEME ANTICOAGULANT DU SANG LORS DE L'ADMINISTRATION INTRAVEINEUSE DU FACTEUR XIII ET DE THROMBOPLASTINELYAPINA LA; YL'YANOV AM; ZHITNIKOVA ES et al.1976; FIZIOL. ZH. S.S.S.R.; S.S.S.R.; DA. 1976; VOL. 62; NO 8; PP. 1166-1170; ABS. ANGL.; BIBL. 15 REF.Article

Measurement of factor XIII activity in plasmaKATONA, Eva; PENZES, Krisztina; MOLNAR, Eva et al.Clinical chemistry and laboratory medicine. 2012, Vol 50, Num 7, pp 1191-1202, issn 1434-6621, 12 p.Conference Paper

CROSS-LINKING OF ALPHA ₂-PLASMIN INHIBITOR TO FIBRIN CATALYZED BY ACTIVATED FIBRIN-STABILIZING FACTORTAMAKI T; AOKI N.1982; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1982; VOL. 257; NO 24; PP. 14767-14772; BIBL. 37 REF.Article

CLOT RETRACTION IN A FACTOR XIII FREE SYSTEMMURALI KRISHNA RAO K; NEWCOMB TF.1980; SCAND. J. HAEMATOL.; DNK; DA. 1980; VOL. 24; NO 2; PP. 142-148; BIBL. 2 P.Article

DIFFERENCES BETWEEN TYPE I AUTOIMMUNE INHIBITORS OF FIBRIN STABILIZATION IN TWO PATIENTS WITH SEVERE HEMORRHAGIC DISORDER.LOPACIUK S; BYKOWSKA K; MCDONAGH JM et al.1978; J. CLIN. INVEST.; U.S.A.; DA. 1978; VOL. 61; NO 5; PP. 1196-1203; BIBL. 33 REF.Article

SIGNIFICANCE OF CROSS-LINKING OF ALPHA ₂-PLASMIN INHIBITOR TO FIBRIN IN INHIBITION OF FIBRINOLYSIS AND IN HEMOSTASISSAKATA Y; AOKI N.1982; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1982; VOL. 69; NO 3; PP. 536-542; BIBL. 29 REF.Article

FIBRIN CROSS-LINKING IN CONGENITAL FACTOR XIII DEFICIENCYRODEGHIERO F; BARBUI T.1980; J. CLIN. PATHOL.; GBR; DA. 1980; VOL. 33; NO 5; PP. 434-437; BIBL. 22 REF.Article

FACTOR XIII DEFICIENCY. A FAMILY STUDY BY MEASUREMENT OF FACTOR XIII SUBUNITS A AND SFRANCIS JL; TODD PJ.1979; ACTA HAEMATOL.; CHE; DA. 1979; VOL. 62; NO 3; PP. 167-172; BIBL. 21 REF.Article

COMPARATIVE STUDY ON BLOOD COAGULATION FACTOR XIIILAPACIUK S; MCDONAGH RP; MCDONAGH J et al.1978; PROC. SOC. EXPER. BIOL. MED.; USA; DA. 1978; VOL. 158; NO 1; PP. 68-72; BIBL. 14 REF.Article

LE DEFICIT CONGENITAL EN FACTEUR STABILISANT DE LA FIBRINE (FACTEUR XIII). A PROPOS D'UNE NOUVELLE OBSERVATION.RENARD X.1976; ; S.L.; DA. 1976; PP. 1-124; BIBL. 14 P.; (THESE DOCT. MED.; REIMS)Thesis

LE DEFICIT CONGENITAL EN FACTEUR STABILISANT DE LA FIBRINE (FACTEUR XIII).DUPOIRIEUX J; FITOUSSI PS; RENARD X et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 43; PP. 2941-2943; BIBL. 10 REF.Article

Novel aspects of factor XIII deficiencyMUSZBEK, László; BAGOLY, Zsuzsa; CAIRO, Andrea et al.Current opinion in hematology. 2011, Vol 18, Num 5, pp 366-372, issn 1065-6251, 7 p.Article

Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation : Infections and the role of plasma proteins and plateletsHOPPE, Berthold.Thrombosis and haemostasis. 2014, Vol 112, Num 4, pp 649-658, issn 0340-6245, 10 p.Article

Thrombelastographic studies on factor XIIISCHROEDER, Verena; KOHLER, Hans P.Thrombosis and haemostasis. 2010, Vol 104, Num 6, pp 1277-1279, issn 0340-6245, 3 p.Article

Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitutionMORANGE, Pierre; TRIGUI, Nawel; FRERE, Corinne et al.Blood coagulation & fibrinolysis. 2009, Vol 20, Num 7, pp 605-606, issn 0957-5235, 2 p.Article